377 related articles for article (PubMed ID: 29540834)
21. LKB1; linking cell structure and tumor suppression.
Hezel AF; Bardeesy N
Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
[TBL] [Abstract][Full Text] [Related]
22. Differential requirements for STRAD in LKB1-dependent functions in C. elegans.
Narbonne P; Hyenne V; Li S; Labbé JC; Roy R
Development; 2010 Feb; 137(4):661-70. PubMed ID: 20110331
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
[TBL] [Abstract][Full Text] [Related]
24. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
[TBL] [Abstract][Full Text] [Related]
25. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.
Karuman P; Gozani O; Odze RD; Zhou XC; Zhu H; Shaw R; Brien TP; Bozzuto CD; Ooi D; Cantley LC; Yuan J
Mol Cell; 2001 Jun; 7(6):1307-19. PubMed ID: 11430832
[TBL] [Abstract][Full Text] [Related]
26. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
[TBL] [Abstract][Full Text] [Related]
27. LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors.
Trelford CB; Shepherd TG
Cell Commun Signal; 2024 Jun; 22(1):310. PubMed ID: 38844908
[TBL] [Abstract][Full Text] [Related]
28. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
[TBL] [Abstract][Full Text] [Related]
29. The tumor suppressor kinase LKB1: lessons from mouse models.
Ollila S; Mäkelä TP
J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
[TBL] [Abstract][Full Text] [Related]
30. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
Su GH; Hruban RH; Bansal RK; Bova GS; Tang DJ; Shekher MC; Westerman AM; Entius MM; Goggins M; Yeo CJ; Kern SE
Am J Pathol; 1999 Jun; 154(6):1835-40. PubMed ID: 10362809
[TBL] [Abstract][Full Text] [Related]
31. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity.
Mehenni H; Gehrig C; Nezu J; Oku A; Shimane M; Rossier C; Guex N; Blouin JL; Scott HS; Antonarakis SE
Am J Hum Genet; 1998 Dec; 63(6):1641-50. PubMed ID: 9837816
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the LKB1-STRAD-MO25 complex.
Boudeau J; Scott JW; Resta N; Deak M; Kieloch A; Komander D; Hardie DG; Prescott AR; van Aalten DM; Alessi DR
J Cell Sci; 2004 Dec; 117(Pt 26):6365-75. PubMed ID: 15561763
[TBL] [Abstract][Full Text] [Related]
33. Regulation of LKB1/STRAD localization and function by E-cadherin.
Sebbagh M; Santoni MJ; Hall B; Borg JP; Schwartz MA
Curr Biol; 2009 Jan; 19(1):37-42. PubMed ID: 19110428
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
35. LKB1 tumor suppressor protein regulates actin filament assembly through Rho and its exchange factor Dbl independently of kinase activity.
Xu X; Omelchenko T; Hall A
BMC Cell Biol; 2010 Oct; 11():77. PubMed ID: 20939895
[TBL] [Abstract][Full Text] [Related]
36. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
Tiainen M; Ylikorkala A; Mäkelä TP
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
[TBL] [Abstract][Full Text] [Related]
37. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells.
Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH
Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
39. A novel germline mutation of the LKB1 gene in a patient with Peutz-Jeghers syndrome with early-onset gastric cancer.
Takahashi M; Sakayori M; Takahashi S; Kato T; Kaji M; Kawahara M; Suzuki T; Kato S; Kato S; Shibata H; Murakawa Y; Yoshioka T; Ishioka C
J Gastroenterol; 2004 Dec; 39(12):1210-4. PubMed ID: 15622488
[TBL] [Abstract][Full Text] [Related]
40. De novo germline mutation in the serine-threonine kinase STK11/LKB1 gene associated with Peutz-Jeghers syndrome.
Hernan I; Roig I; Martin B; Gamundi MJ; Martinez-Gimeno M; Carballo M
Clin Genet; 2004 Jul; 66(1):58-62. PubMed ID: 15200509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
